Evidence map›Paper›PMID 39289194›Full record

ArticleCell biology and toxicology2024

TRMT10C-mediated m7G modification of circFAM126A inhibits lung cancer growth by regulating cellular glycolysis.

Qingyun Zhao, Xiaofei Li, Jiaxi Wu, Ruirui Zhang, Sixian Chen, Dunyu Cai, Haotian Xu, Wenyi Peng, Gang Li, Aruo Nan

Abstract read
In one paragraph

Article in Cell biology and toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. o8G-modified circKIAA1797 promotes lung cancer development by inhibiting cuproptosis.Journal of experimental & clinical cancer research : CR · 2025
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Qingyun ZhaoSchool of Public Health, Guangxi Medical University, Nanning, 530021, China.
Xiaofei LiSchool of Public Health, Guangxi Medical University, Nanning, 530021, China.
Jiaxi WuSchool of Public Health, Guangxi Medical University, Nanning, 530021, China.
Ruirui ZhangSchool of Public Health, Guangxi Medical University, Nanning, 530021, China.
Sixian ChenSchool of Public Health, Guangxi Medical University, Nanning, 530021, China.
Dunyu CaiSchool of Public Health, Guangxi Medical University, Nanning, 530021, China.
Haotian XuSchool of Public Health, Guangxi Medical University, Nanning, 530021, China.
Wenyi PengSchool of Public Health, Guangxi Medical University, Nanning, 530021, China.
Gang LiSchool of Public Health, Guangxi Medical University, Nanning, 530021, China. ligang@gxmu.edu.cn.
Aruo NanSchool of Public Health, Guangxi Medical University, Nanning, 530021, China. nanaruo@163.com.

Funding

Guangxi Science and Technology Base and Talent Special Project no.AD22080055National Natural Science Foundation of China NSFC82260652
6 · The paper itself

Abstract

The N

Indexed as

Cell ProliferationGlycolysisLung NeoplasmsMethyltransferasesRNA, CircularA549 CellsAnimalsCell Line, TumorFemaleGene Expression Regulation, NeoplasticGuanosineHSP90 Heat-Shock ProteinsHumansMaleMiceMice, Inbred BALB CGuanosineHSP90 Heat-Shock ProteinsMethyltransferasesProto-Oncogene Proteins c-aktRNA, CircularcircRNAGlycolysisHSP90Lung cancerm7G modification

Identifiers

PMID39289194
PMCPMC11408563

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.